Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-19

FDA Approved: SILDENAFIL — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approves a supplemental application for sildenafil citrate by Eugia US LLC (ANDA 203988) for a generic sildenafil product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

SUPPL AP for SILDENAFIL (SILDENAFIL CITRATE)